Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | POLE4 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | POU2AF1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | LGALS1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
mRNA | PGAM1 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
mRNA | ITSN2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | PNPLA4 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | HLA-DOB | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | GPX8 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0009 |
mRNA | MAP2K1 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |